Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-22-029277
Filing Date
2022-11-09
Accepted
2022-11-09 16:35:57
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 contexttherapeuticss-3.htm S-3 304354
2 EX-FILING FEES exhibit107-sx3shelf.htm EX-FILING FEES 17284
3 EX-4.3 exhibit43-sx3shelf.htm EX-4.3 409190
4 EX-5.1 exhibit51-sx3shelf.htm EX-5.1 42687
5 EX-23.2 exhibit232-sx3shelf.htm EX-23.2 2404
6 contexttherapeuticsimage.jpg GRAPHIC 32139
7 faegrelogo.jpg GRAPHIC 37568
  Complete submission text file 0001628280-22-029277.txt   873053
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268266 | Film No.: 221373251
SIC: 2834 Pharmaceutical Preparations